The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
How Retail Design Can Improve the Healthcare Patient Experience
Jefferson Health Breaks Ground on Lehigh Valley Hospital—Coopersburg
Encompass Health Plans Second Small-Format Rehabilitation Hospital
Rethinking How Healthcare Facilities Fund Construction Projects
Winners Named for the 15th Annual Healthcare Design Awards